RAD-150
Also known as: TLB-150, TLB-150 benzoate, RAD150
Classification
Sarm
Regulatory Status
not-established
Sources
3
Review
n/a
Overview
RAD-150 (TLB-150 benzoate) is described by chemical suppliers as a benzoate ester derivative of the SARM RAD140 (testolone). Compound-specific human pharmacology is not published.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
androgen receptor modulation (class/parent-compound description)
Interactions & cautions
Drug interactions
other SARMs, anabolic steroids, or androgen receptor agonists — Additive hepatotoxicity, suppression, or lipid/endocrine risk is a class concern. (high)
These are observational flags for review, not individualized instructions.
Sources
- https://www.fda.gov/drugs/fraudulent-products/certain-bodybuilding-products-put-consumers-risk-heart-attack-stroke-serious-liver-damage-and-more (opens in a new tab)
- https://www.ncbi.nlm.nih.gov/books/NBK619971/ (opens in a new tab)
- https://pubchem.ncbi.nlm.nih.gov/compound/68547459 (opens in a new tab)
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw